MedTrace Logo

Signet Ring Cell Carcinoma in Esophageal Adenocarcinoma

NCT01824966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82

Last updated 2013-04-05

No results posted yet for this study

Summary

There has been much controversy surrounding the biologic behavior and prognosis of esophageal signet ring cell (SRCs) containing carcinomas. To clarify the biologic behavior of SRCs, the investigators compared the clinicopathologic features and prognosis of SRCs with other adenocarcinomas (ADC) of the esophagus and gastroesophageal junction (GEJ).

Conditions

  • Adenocarcinoma
  • Esophageal Cancer

Sponsors & Collaborators

  • University Hospital, Gasthuisberg

    lead OTHER

Principal Investigators

  • Philippe Nafteux, MD · University Hospital Leuven; Dept. of Thoracic Surgery

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01824966 on ClinicalTrials.gov